Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Whitehawk Therapeutics Inc WHWK

Healthcare Biotechnology
Aadi Bioscience, Inc. is a precision oncology company. The Company is focused on applying technology to deliver improved precision oncology therapies for people living with difficult-to-treat cancers.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:WHWK)

Aadi Bioscience to Report Fourth Quarter and Full-Year 2024 Results and Corporate Update

PR Newswire 10 days ago

Aadi Bioscience Announces Closing of $100 Million PIPE Financing

PR Newswire March 4, 2025

Aadi Bioscience Announces Approval of All Proposals at Special Meeting of Stockholders

PR Newswire March 3, 2025

Aadi Bioscience to Present at the TD Cowen 45th Annual Healthcare Conference

PR Newswire February 24, 2025

Aadi Bioscience Appoints David Dornan, PhD, as Chief Scientific Officer

PR Newswire February 18, 2025

Aadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025

PR Newswire February 5, 2025

Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing

PR Newswire December 19, 2024

Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update

PR Newswire November 6, 2024

Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update

PR Newswire October 30, 2024
View More News ››

Opinion & Analysis (NDAQ:WHWK)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:WHWK)

Aadi Bioscience (NASDAQ:AADI) &#8211; Unlocking the Full Pot

https://beyondspx.com/article/aadi-bioscience-nasdaqaadi-unlocking-the-full-potential-of-mtor-inhibition
MikeTester - January 22, 2025

ZACKS NEW #1 STRONGEST BUY

Better than expected earnings expected and is currently a Zack's STRONG buy. Price target of 40% upside.    READ THE...
yorgosGK - April 16, 2020
View more Bullboard ››

Xcyte Digital Corp.

Xcyte Digital Corp.

Xcyte Digital is a virtual event company focused on simplifying the event hosting industry and expanding event hosting ...
View More »